iDose TR Sustained-release Travoprost Implant for the Treatment of Glaucoma
Parul Ichhpujani, Sahil Thakur
touchREVIEWS in Ophthalmology. 2023;17(1):4–7 DOI: https://doi.org/10.17925/USOR.2023.17.1.4
The challenge of patient adherence Patient adherence is a major concern in the field of glaucoma, where medication adherence rates can be as low as 40–55% due to complex dosing regimens, unpleasant side effects and difficulty with eyedrop administration.1,2 Moreover, 25% of patients with glaucoma do not refill their second eyedrop prescription, making it challenging for […]